PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2016 Edition

Table of Contents

Executive Summary 1
Industry Structure and Size 3
Industry Size and Growth 9
CMO Market Shares 12
The Outlook for the Dose CMO Industry 14
Appendix 21
Methodology for Market Size and Growth Estimates 21

List of Tables

Table 1 Summary of CMO Facility Acquisition Activity 2012-2015
Table 2 CMO Acquisitions of Bio/Pharmaceutical Company Facilities 2015
Table 3 Acquisitions of CMOs by CMOs 2015
Table 4 Selected Exits from the Dose CMO Sector 2015
Table 5 Private Equity Investment Activity in 2015
Table 6 Private Equity Investments in the Dose CMO Industry 2011-2015
Table 7 Revenue Comparison of Leading CMOs 2012-2015

List of Figures

Figure 1 Geographic Reach of Dose CMO Universe
Figure 2 Distribution of Dose CMOs by Revenue (Number of CMOs)
Figure 3 Dose CMO Market Size 2009-2015
Figure 4 Dose CMO Dosage Form Segments ($ billion)
Figure 5 Dose CMO Industry Market Share by Company Size
Figure 6 FDA NDA Approvals 2010-2015
Figure 7 Outsourcing Propensity of Global Bio/Pharma Companies 2006-2015
Figure 8 Orphan NMEs approved by the FDA 2010-2015
Figure A1 Company Bridge from 2015 Report to 2016 Report